Kenji Akita Selected Research

Muscle Weakness

6/2022

Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Akita Research Topics

Disease

6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 09/2002
4	Neoplasms (Cancer) 09/2023 - 09/2002
1	Fatigue 06/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2022
1	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 06/2022
1	Muscle Weakness 06/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2022
1	Pneumonia (Pneumonitis) 02/2022
1	Stomach Neoplasms (Stomach Cancer) 02/2022
1	Lung Diseases (Lung Disease) 02/2022
1	Lymphatic Metastasis 01/2021
1	Infections 12/2020
1	Chylous Ascites 12/2020
1	Flatulence 04/2012
1	Colonic Neoplasms (Colon Cancer) 04/2012
1	Lung Neoplasms (Lung Cancer) 04/2012
1	Cognitive Dysfunction 01/2012
1	Dementia (Dementias) 01/2012
1	Memory Disorders (Memory Loss) 01/2012
1	Amnesia (Dissociative Amnesia) 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2011
1	Febrile Neutropenia 01/2010
1	Brain Edema (Cerebral Edema) 01/2010
1	Brain Injuries (Brain Injury) 01/2010
1	Brain Ischemia (Cerebral Ischemia) 01/2010
1	Ischemia 01/2010
1	Reperfusion Injury 01/2010
1	Breast Neoplasms (Breast Cancer) 01/2005
1	Cough 01/2005
1	Fever (Fevers) 01/2005
1	Cryptogenic Organizing Pneumonia 01/2005
1	Sarcoidosis (Schaumann Disease) 03/2004
1	Tuberculosis (Tuberculoses) 03/2004
1	Granuloma 03/2003
1	Rheumatoid Arthritis 03/2003
1	Erythema Nodosum 03/2003
1	Osteoarthritis 03/2003

Drug/Important Bio-Agent (IBA)

2	Coloring Agents (Dyes)IBA 01/2012 - 01/2010
2	Nerve Growth Factors (Neurotrophins)IBA 02/2011 - 01/2010
1	GoldIBA 09/2023
1	atezolizumabIBA 06/2022
1	NivolumabIBA 02/2022
1	Immune Checkpoint InhibitorsIBA 02/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	AutoantibodiesIBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	InterferonsIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 04/2012
1	Amino Acids FDA Link 04/2012
1	Hyaluronic Acid (Hyaluronan)IBA 04/2012
1	Methionine (L-Methionine)FDA Link 04/2012
1	SugarsIBA 04/2012
1	SulfurIBA 04/2012
1	Amyloid beta-PeptidesIBA 01/2012
1	Cholinergic Agents (Cholinergics)IBA 01/2012
1	Peptides (Polypeptides)IBA 01/2012
1	AcetylcholinesteraseIBA 01/2012
1	Scopolamine (Hyoscine)FDA Link 01/2012
1	amrubicinIBA 01/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2010
1	AnthracyclinesIBA 01/2010
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 03/2004
1	Antirheumatic Agents (DMARD)IBA 03/2003
1	Muramidase (Lysozyme)IBA 03/2003
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2002

Therapy/Procedure

5	Proton Therapy 04/2024 - 10/2018
4	Therapeutics 06/2022 - 09/2002
2	Radiotherapy 09/2023 - 01/2005
1	Immunotherapy 02/2022
1	Aftercare (After-Treatment) 12/2020
1	Adjuvant Radiotherapy 01/2005
1	Play Therapy (Therapy, Play) 09/2002